Posts by ericg
Five things to know: Newbury Street retail, cannabis news, and your personal ‘year in review’
Good morning. Here are the five things you need to know in Boston business news to start your day, including Newbury Street retail, cannabis news, a videogame company lease, and your personal "year in review" Read More
Read MoreMass. fiscal group, municipal politicians press for more tax relief
Municipal officials pleaded with Beacon Hill lawmakers Thursday to pursue broader tax cuts in the new year. Read More
Read MoreMass. cannabis chain Theory Wellness goes employee-owned
Theory Wellness has become the state’s first employee-owned cannabis company, and the largest cannabis company nationally to execute an employee stock ownership plan. Read More
Read MoreAllurion’s SPAC deal came amid renewed attention on weight loss
Allurion Technologies reached a milestone this year when the Natick maker of a weight-loss balloon went public via SPAC deal. It happened to come at a time when everyone was paying attention to high-profile weight-loss treatments. Read More
Read MoreScape scores $178M in refinancing for Fenway apartment building
The real estate firm opened leasing at the Boylston Street complex about a year ago. Read More
Read MoreReturn of IPOs, fewer unicorns and more startup predictions for 2024
What’s in store for startups in 2024? An increase in public offerings, a renewed appetite from large corporations in startup investing and fewer active "unicorn" startups with billion-dollar valuations. Read More
Read MoreBluebikes extends naming rights through 2031, adds ebikes
The Boston area’s bikeshare program will be known as Bluebikes through 2031, and the network is adding its first of 750 planned ebikes. Read More
Read MoreDozens of new names opened on Newbury Street this year, and more retail news
Newbury Street added roughly two dozen new names in 2023, including some just in time for the holidays. Plus, Korean BBQ in the suburbs and Dunkin’ could take over a former Starbucks site. Read More
Read MoreYear in review: Upheaval marked the Mass. cannabis industry in 2023
Here were three of the biggest stories in the Massachusetts cannabis industry in 2023. Read More
Read MoreThe Petri Dish: ADHD-treating videogame cleared for teens, CRISPR exec resigns
Just six days after her company’s landmark sickle-cell drug was approved in the U.S., CRISPR Therapeutics’ chief medical officer resigned. Plus, other life sciences news you may have missed. Read More
Read More